Zyprexa Whistleblower Wants To Switch Courts

Law360, New York (October 19, 2007, 12:00 AM EDT) -- A former Eli Lilly & Co. employee has sought to remove her whistleblower suit over allegations that the pharmaceutical giant marketed its blockbuster anti-psychotic drug Zyprexa for off-label uses to a California superior court, saying Lilly cannot demonstrate that her state law claims invoke “substantial federal questions.”

In court documents filed Friday in the U.S. District Court for the Northern District of California, plaintiff Jaydeen Vincente said that Lilly's removal of the case from San Francisco Superior Court in September based on federal question jurisdiction lacks...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.